Brightenex™
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
02.12.2015
5th Annual Meeting World Academy of Cosmetic Surgery, June 24 – 25, 2016
We have put together the best photos of the Annual Meeting which you can see further down in our photo gallery. The special issue of Cosmetic Medicine with the […]
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]